| Literature DB >> 28135245 |
Jian Zhao1,2, Jianyang Ma3, Yun Deng1,2, Jennifer A Kelly4, Kwangwoo Kim5, So-Young Bang6, Hye-Soon Lee6, Quan-Zhen Li7, Edward K Wakeland7, Rong Qiu8, Mengru Liu9, Jianping Guo9, Zhanguo Li9, Wenfeng Tan10, Astrid Rasmussen4, Christopher J Lessard4,11, Kathy L Sivils4,11, Bevra H Hahn2, Jennifer M Grossman2, Diane L Kamen1, Gary S Gilkeson1, Sang-Cheol Bae6, Patrick M Gaffney4, Nan Shen3,8,12,13,14, Betty P Tsao1,2.
Abstract
Systemic lupus erythematosus (SLE) is a heterogeneous autoimmune disease with a strong genetic component characterized by autoantibody production and a type I interferon signature. Here we report a missense variant (g.74779296G>A; p.Arg90His) in NCF1, encoding the p47phox subunit of the phagocyte NADPH oxidase (NOX2), as the putative underlying causal variant that drives a strong SLE-associated signal detected by the Immunochip in the GTF2IRD1-GTF2I region at 7q11.23 with a complex genomic structure. We show that the p.Arg90His substitution, which is reported to cause reduced reactive oxygen species (ROS) production, predisposes to SLE (odds ratio (OR) = 3.47 in Asians (Pmeta = 3.1 × 10-104), OR = 2.61 in European Americans, OR = 2.02 in African Americans) and other autoimmune diseases, including primary Sjögren's syndrome (OR = 2.45 in Chinese, OR = 2.35 in European Americans) and rheumatoid arthritis (OR = 1.65 in Koreans). Additionally, decreased and increased copy numbers of NCF1 predispose to and protect against SLE, respectively. Our data highlight the pathogenic role of reduced NOX2-derived ROS levels in autoimmune diseases.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28135245 PMCID: PMC5400098 DOI: 10.1038/ng.3782
Source DB: PubMed Journal: Nat Genet ISSN: 1061-4036 Impact factor: 41.307